Arch Therapeutics Raises Approximately $3.5 Million in Convertible Note Financing
July 07, 2022 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., July 07, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
June 22, 2022 09:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces plans to conduct additional internal quality control testing for their new Vitastem products....
Arch Therapeutics Provides Update on Reimbursement Strategy in Additional Selling Channel
June 22, 2022 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., June 22, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Amniotic Products Market Size, $1.88Bn by 2028, 8.4% CAGR Lead by Amniotic Membranes (8.9% CAGR in 2022) | The Insight Partners
June 16, 2022 07:53 ET
|
The Insight Partners
New York, June 16, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Amniotic Products Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type...
Kane Biotech Announces Extension of Private Placement Offering
April 29, 2022 16:05 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Perceptive Solutions Integrates With MatrixCare, Post-Acute EHR Software
April 26, 2022 08:00 ET
|
Perceptive Solutions, Inc.
STEVENS POINT, Wis., April 26, 2022 (GLOBE NEWSWIRE) -- Perceptive Solutions, Inc., developer of WoundZoom Digital Wound Management, today announced its integration partnership with MatrixCare. The...
Renowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Spring
April 13, 2022 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 13, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics’ AC5® Advanced Wound System to be Presented at 2022 Symposium on Advanced Wound Care (SAWC) Spring
April 04, 2022 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
March 31, 2022 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...
Depicting a thorough investigation and analysis on risk factors for non-healing or chronic wounds - MDC Research
March 29, 2022 11:26 ET
|
Market Data Centre
Pune, March 29, 2022 (GLOBE NEWSWIRE) -- Advanced wound care products are designed to treat acute & chronic wounds. Advanced wound care is developing as a standard solution for treating chronic...